Man Group’s Esperion Therapeutics ESPR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-25,692
| Closed | -$42.4K | – | 1883 |
|
2024
Q3 | $42.4K | Buy |
+25,692
| New | +$42.4K | ﹤0.01% | 1784 |
|
2024
Q2 | – | Sell |
-440,770
| Closed | -$1.18M | – | 1946 |
|
2024
Q1 | $1.18M | Buy |
440,770
+223,785
| +103% | +$600K | ﹤0.01% | 1374 |
|
2023
Q4 | $649K | Buy |
+216,985
| New | +$649K | ﹤0.01% | 1479 |
|
2023
Q3 | – | Sell |
-117,251
| Closed | -$163K | – | 1837 |
|
2023
Q2 | $163K | Buy |
+117,251
| New | +$163K | ﹤0.01% | 1802 |
|
2023
Q1 | – | Sell |
-18,100
| Closed | -$113K | – | 1923 |
|
2022
Q4 | $113K | Buy |
+18,100
| New | +$113K | ﹤0.01% | 1885 |
|
2022
Q3 | – | Hold |
0
| – | -$300K | – | 2032 |
|
2022
Q2 | – | Sell |
-112,903
| Closed | -$524K | – | 1686 |
|
2022
Q1 | $524K | Buy |
+112,903
| New | +$524K | ﹤0.01% | 1546 |
|
2021
Q4 | – | Sell |
-15,756
| Closed | -$190K | – | 1907 |
|
2021
Q3 | $190K | Buy |
15,756
+1,978
| +14% | +$23.9K | ﹤0.01% | 1745 |
|
2021
Q2 | $291K | Sell |
13,778
-14,248
| -51% | -$301K | ﹤0.01% | 1678 |
|
2021
Q1 | $786K | Sell |
28,026
-9,554
| -25% | -$268K | ﹤0.01% | 1355 |
|
2020
Q4 | $977K | Buy |
37,580
+19,969
| +113% | +$519K | ﹤0.01% | 1418 |
|
2020
Q3 | $655K | Buy |
17,611
+281
| +2% | +$10.5K | ﹤0.01% | 1480 |
|
2020
Q2 | $889K | Buy |
17,330
+10,992
| +173% | +$564K | ﹤0.01% | 1306 |
|
2020
Q1 | $200K | Sell |
6,338
-276,658
| -98% | -$8.73M | ﹤0.01% | 1459 |
|
2019
Q4 | $16.9M | Buy |
282,996
+76,369
| +37% | +$4.55M | 0.06% | 419 |
|
2019
Q3 | $7.58M | Sell |
206,627
-52,056
| -20% | -$1.91M | 0.03% | 682 |
|
2019
Q2 | $12M | Buy |
258,683
+24,566
| +10% | +$1.14M | 0.04% | 542 |
|
2019
Q1 | $9.4M | Buy |
234,117
+70,331
| +43% | +$2.82M | 0.04% | 599 |
|
2018
Q4 | $7.54M | Buy |
163,786
+20,218
| +14% | +$930K | 0.03% | 564 |
|
2018
Q3 | $6.37M | Buy |
143,568
+120,357
| +519% | +$5.34M | 0.02% | 849 |
|
2018
Q2 | $910K | Buy |
+23,211
| New | +$910K | ﹤0.01% | 1618 |
|